TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Vistin Pharma ASA
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
270,219
|
288,679
|
203,226 |
| Financial expenses |
9,167
|
20,501
|
6,687 |
| Earnings before taxes |
50,666
|
38,799
|
-4,244 |
| Total assets |
242,418
|
267,465
|
287,673 |
| Current assets |
90,172
|
111,903
|
112,453 |
| Current liabilities |
40,284
|
46,064
|
83,215 |
| Equity capital |
194,925
|
214,007
|
193,045 |
| - share capital |
27,926
|
29,402
|
31,327 |
| Employees (average) | 0 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
80.4%
|
80.0%
|
67.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
18.7%
|
13.4%
|
-2.1% |
| Return on assets (ROA) |
24.7%
|
22.2%
|
0.8% |
| Current ratio |
223.8%
|
242.9%
|
135.1% |
| Return on equity (ROE) |
26.0%
|
18.1%
|
-2.2% |
| Change turnover |
-3,967
|
97,941
|
8,381 |
| Change turnover % |
-1%
|
51%
|
4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.